Transfer marks start of vital development stage as company expands its range of synthesized DNA
Updated Date: Tue, 02 May 2023 00:00:00 EDT
CMAJ, the journal of the Canadian Medical Association (CMA), is closing its news section and its online open […]
Key messagesIn Europe, the number of approvals for new drugs targeting rare diseases (orphan drugs) has risen sharply […]
Patients in England will be able to get prescription drugs without seeing a GP, under a government plan […]
On paper, a GP’s working schedule can look quite inviting: consulting for three and a half hours in […]
Four years, four culture secretaries, and six gambling ministers after promising to review the 2005 Gambling Act, the […]
Heath and Montori’s article on responding to the crisis in modern healthcare reminded me of Robert Lustig’s words: […]
AbstractObjectiveTo analyze the US Food and Drug Administration (FDA) approval, trials, unmet needs, benefit, and pricing of ultra-rare […]
In 1983 the US Congress enacted the Orphan Drug Act, establishing financial incentives for companies to develop new […]